Patient
P2B-088
withdrawn Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · State Health Centre Oncology Department (Budapest, Hungary) (Dr. Clarke)
consented 2013-03-16
Adverse events
1
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 1
Grade 3 anaemia with onset in cycle 2 (2013-05-08); assessed as related to study drug (probable); resolved 2013-06-17; action: drug interrupted.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.